Lewes, DE -- (SBWIRE) -- 03/10/2016 -- Report forecast the global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020.

Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions.

Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers.

Pathologists use different technologies such as in situ hybridization (ISH), immunohistochemistry (IHC), special staining, and digital pathology and related methods including core biopsy, fine needle aspiration cytology, and open biopsy to study and diagnose cells.

The report covers the present scenario and the growth prospects of the global tissue diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of diagnostic devices based on the following techniques:
- Advanced staining
- Preanalytical and routine staining
- Digital pathology

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

According to the report, hospital-based pathology laboratories widely use tissue diagnostics for disease diagnosis, while pharmaceutical companies use them for drug discovery. Advances in technology are leading academia and research institutes, reference pathology laboratories, and medical research centers worldwide to use tissue diagnostics for various medical purposes. The implementation of tissue diagnostics by these new consumers can become a turning point for the market in the coming years.

Further, the report states that the insurance coverage and reimbursement policies for tissue diagnostics continue to concern policy makers and are leading individuals to opt for conventional therapies.

Global Tissue Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the Global Tissue Diagnostics Market: Abbott Diagnostics, Agilent Technologies (a parent company of Dako), Danaher (a parent company of Leica Biosystems) and Roche Diagnostics.

Other Prominent Vendors in the market are: 20/20 GeneSystems, Abcam, AdnaGen, Advanced Cell Diagnostics, Affymetrix, Agendia, AutoGenomics, AVIVA BioSciences, Biocare Medical, Biocartis, Cancer Genetics, ELITechGroup, Enzo Biochem, Epic Sciences, Fluidigm, HORIBA Medical, Janssen Diagnostics, Olympus Diagnostics Systems Group, Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US), Oxford Gene Technology, PANAGENE, Protea Biosciences Group and Sakura Finetek

Market driver
- Implementation by new customers
- For a full, detailed list, view our report

Market challenge
- Insurance coverage and reimbursement issues
- For a full, detailed list, view our report

Market trend
- Ready-to-use reagents
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 72 pages and 57 Exhibits "Global Tissue Diagnostics Market 2016 - 2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Global cancer statistics, Reimbursement and coverage: An overview, Market segmentation by technology, Market segmentation by product, Market segmentation by disease, Market segmentation by end-user, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://www.marketresearchreports.com/technavio/global-tissue-diagnostics-market-2016-2020

Related Reports :

Global Tissue Heart Valves Market 2016-2020 - http://www.marketresearchreports.com/technavio/global-tissue-heart-valves-market-2016-2020

Global Oncology Biosimilars Market 2016-2020 - http://www.marketresearchreports.com/technavio/global%C2%A0oncology%C2%A0biosimilars-market-2016-2020

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions